LabCorp Is Scheduled to Present at the 2020 Barclays Global Healthcare Conference
March 02 2020 - 4:35PM
Business Wire
LabCorp® (NYSE: LH) today announced that members of the
executive management team will participate in a fireside chat at
the Barclays Global Healthcare Conference in Miami Beach on
Tuesday, March 10 at 8:30 a.m. ET.
A live audio webcast of the presentation will be available via
the Company website at www.LabCorp.com and archived for replay.
About LabCorp LabCorp (NYSE: LH), an S&P 500 company,
is a leading global life sciences company that is deeply integrated
in guiding patient care, providing comprehensive clinical
laboratory and end-to-end drug development services. With a mission
to improve health and improve lives, LabCorp delivers world-class
diagnostic solutions, brings innovative medicines to patients
faster, and uses technology to improve the delivery of care.
LabCorp reported revenue of more than $11.5 billion in 2019. To
learn more about LabCorp, visit www.LabCorp.com, and to learn more
about Covance Drug Development, visit www.Covance.com.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements, including,
but not limited to, statements with respect to the impact of
various factors on operating and financial results, future business
strategies, expected savings and synergies, and the opportunities
for future growth. Each of the forward-looking statements is
subject to change based on various important factors, many of which
are beyond the Company’s control, including without limitation,
competitive actions and other unforeseen changes and general
uncertainties in the marketplace, changes in government
regulations, including healthcare reform, customer purchasing
decisions, including changes in payer regulations or policies,
other adverse actions of governmental and third-party payers,
changes in testing guidelines or recommendations, the effect of
public opinion on the Company’s reputation, adverse results in
material litigation matters, the impact of changes in tax laws and
regulations, failure to maintain or develop customer relationships,
our ability to develop or acquire new products and adapt to
technological changes, failure in information technology, systems
or data security, adverse weather conditions, employee relations,
and the effect of exchange rate fluctuations. These factors, in
some cases, have affected and in the future (together with other
factors) could affect the Company’s ability to implement the
Company’s business strategy and actual results could differ
materially from those suggested by these forward-looking
statements. As a result, readers are cautioned not to place undue
reliance on any of our forward-looking statements. The Company has
no obligation to provide any updates to these forward-looking
statements even if its expectations change. All forward-looking
statements are expressly qualified in their entirety by this
cautionary statement. Further information on potential factors,
risks and uncertainties that could affect operating and financial
results is included in the Company’s most recent Annual Report on
Form 10-K and subsequent Forms 10-Q, including in each case under
the heading RISK FACTORS, and in the Company’s other filings with
the SEC. The information in this press release should be read in
conjunction with a review of the Company’s filings with the SEC
including the information in the Company’s most recent Annual
Report on Form 10-K, and subsequent Forms 10-Q, under the heading
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200302005990/en/
Investors: Clarissa Willett - 336-436-5076
Investor@LabCorp.com
Media: Pattie Kushner - 336-436-8263 Media@LabCorp.com
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Apr 2023 to Apr 2024